Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/15/2017
Update on Antitrust Legislative Development in China
11/15/2017
Competition Impact Review to Be Required for All New Chinese Regulatio...
11/15/2017
China Issues New Measure to Ensure Fair Competition
11/15/2017
Is Walgreens Boots Alliance Pulling Out of Chinese JV Guangzhou Pharma
11/14/2017
Reckitt Benckiser, Alibaba Join Hands to Market Quality Health Product...
11/14/2017
Shanghai Pharma Buys Cardinal Health's China Business for $1.2B
11/13/2017
XiAn Janssen Launches IMBRUVICA (ibrutinib) in China
11/13/2017
Pfizer Divests from Chinese JV with Hisun
11/9/2017
AstraZeneca Bets on Continued Growth in China as GSK Fades
11/9/2017
Recent Executive Moves
11/9/2017
SMEI: Chinese Drug Sales Growth Expected to Fall Further in 2017
11/8/2017
Tsumura to Penetrate China's Herbal Drug Market with the Help of Ping ...
11/8/2017
Biotest and Tiancheng Pharma to Rework Their Acquisition Deal after Na...
11/8/2017
CBMG Opens New Facility and Joint Lab for Cell Therapy in Shanghai
11/8/2017
Xynomic Licenses Global Rights of RAF Inhibitor from Boehringer Ingelh...
11/7/2017
EddingPharm Spinoff Strives to Bring Potential Oncology Blockbusters t...
11/6/2017
CFDA Accepts BMS's NDA for Optivo (Nivolumab)
11/6/2017
SIMM Granted Clinical Trial Approval for New Alzheimer's Drug
11/6/2017
Eisai Submits Chinese NDA for Hepatic Cancer Drug Lenvima
11/3/2017
Fosun to Acquire the Ramaining 69.25% Stake in Taiwan-Based Henlix Bio...
11/3/2017
Sinotau, HTA to Co-market A New β-amyloid Imaging Agent in China
11/3/2017
iPharma Licenses Worldwide Rights of Boehringer Ingelheim's FAKi BI 85...
11/3/2017
Recent Official and Executive Moves
11/2/2017
China to Build Gigantic DNA Storing Facility in Nanjing
11/1/2017
Chi-Med InitiatesPhase III Trial of Fruquintinib in Second-Line Gastri...
10/31/2017
Three Trends in Pharma Globalization
10/31/2017
Financial-related Company News in Brief (10/2017)
10/31/2017
CFDA Suspends Sales of Imported Fat Emulsion for Non-Compliance of Chi...
10/30/2017
CDE Solicits Commits on Research and Evaluation Considerations for Bio...
10/30/2017
Sinovac Biotech Completes Phase III Trial of 23-Valent Pneumococcal Po...
Page:
151
/
334
Total number of articles:
10001
:
[First]
[<<]
[149]
[150]
[151]
[152]
[153]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit